Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-01-26 @ 8:18 AM
Study NCT ID:
NCT04816669
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2021-03-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
Sponsor:
BioNTech SE
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C4591020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |